MONOXYDE D’AZOTE SOL FRANCE 250 ppm mole/mole, medicinal gas tablet cylinder, 5 l
Active ingredients: Nitric oxide
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Gascylinder, 5 linhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MONOXYDE D’AZOTE SOL FRANCE 250 ppm mole/mole, gaz médicinal comprimé
- Pharmaceutical form
- gaz
- Route of administration
- inhalée
- Presentation description
- bouteille(s) aluminium de 5 l avec un corps peint en blanc et une ogive peinte en bleu turquoise
- Marketing authorisation holder
- SOL FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Jul 2021
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60934825CIP75507730CIP133400955077305Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MONOXYDE D'AZOTEgaz | 250 ppm mole · une mole | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.